Hormonal responses to d- and d,l-fenfluramine in healthy human subjects

Neuropsychopharmacology

Volumn 15, Issue 6, 1996, Pages 595-607

  Coccaro, Emil F ^a   Kavoussi, Richard J ^a   Cooper, Thomas B ^b   Hauger, Richard L ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTH; Cortisol; Fenfluramine; Prolactin; Serotonin

Indexed keywords

CORTICOTROPIN; DEXFENFLURAMINE; FENFLURAMINE; PLACEBO; PROLACTIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030560861     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00133-9     Document Type: Article

References (24)

1. Ben-Jonathan N, Abbogast LA, Hyde JF (1989): Neuroendocrine regulation of prolactin release. Prog Neurobiol 33:399-447
2. Coccaro EF, Kavoussi RJ (1994): The neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 40: 319-327
3. Coccaro EF, Klar HM, Siever LJ (1994): Prolactin responsiveness to fenfluramine challenge does not correlate with prolactin responsiveness to TRH challenge in psychiatric patient. Biol Psychiatr 36:344-346
4. Coccaro EF, Kavoussi RJ, Oakes M, Cooper TB, Hauger RL (1996): Amesergide completely blocks the prolactin response to d-fenfluramine in healthy male subjects. Psychopharmacology 126:24-30
5. Crunelli V, Bernasconi S, Samanin R (1980): Effects of d- and l-fenfluramine on striatal homovanillic acid concetrations in rats after pharmacological manipulation of brain serotonin. Pharmacol Res Commun 12:215-223
6. Garattini S, Mennini T, Samanin R (1987): From fenfluramine racemate to d-fenfluramine: Specificity and potency of the effects on the serotonergic system and food intake. Ann NY Acad Sci 499:156-165
7. Garattini S, Bizzi A, Caccia S, Mennini T, Samanin R (1988): Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol 11(suppl):S8-S32
8. Ghigo E, Goffi S, Malinatti GM, Camanni F, Massara F (1985): Prolactin and TRH responses to both domperidone and TRH in normal and hyperprolactinemic women after dopaminergic synthesis blockade. Clin Endocrinol 23: 155-160
9. Goodall EM, Cowan PJ, Franklin M, Silverstone T (1993): Ritanserin attenuates anorectic, endocrine and thermal responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-466
10. Gorard DA, Taylor TM, Medback SH, Perry LA, Libby GW, Farthing MJG (1993): Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Int Clin Psychopharmacol 8:123-128
11. Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Islam MN, Liebowitz MR, Stanley M (1992): Effects of fenfluramine on plasma homovanillic acid in healthy subjects. J Neural Trans 90:81-84
12. Hunneman DH (1983): Mass fragmentographic determination of homovanillic acid and 4-hydroxy-3methoxy mandelic acids in 50 μl plasma. Clin Chem Acta 135:169-174
13. Invernizzi R, Berettera C, Garattini S, Samanin R, (1986): D-and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120:9-15
14. 3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neuroendocrinology 55:336-343
15. Kendler KS, Heninger GH, Roth RH (1981): Brain contribution to the haloperidol-induced increase in plasma homovanillic acid. Eur J Pharmacol 71:321-326
16. Koenig JI, Gudelsky GA, Meltzer HY (1987): Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 137:1-8
17. Krebs HA, Chens LK, Wright GJ (1984): Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatography 310:412-417
18. Mitchell PB, Smythe GA (1991): Endocrine and amine responses to d,1-fenfluramine in normal subjects. Psychiatr Res 39:141-153
19. O'Keane V, Dinan TG (1991): Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. Am J Psychiatr 148:1009-1015
20. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG (1992): Blunted prolactin responses to d-fen-fluramine in sociopathy: Evidence for subsensitivity of central serotonergic function. Br J Psychiatr 160:643-646
21. Park SBG, Cowan PJ (1995): Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118:471-474
22. Silverstone T, Smith G, Richards R (1987): A comparative evaluation of dextrofenfluramine and d/l-fenfluramine on hunger, food intake, psychomotor function, and side effects in normal human subjects. In Bender AE, Brookes LJ, (eds), Body Weight Control: The Physiology, Clinical Treatment and Prevention of Obesity. Edinburgh, Churchill-Livingstone
23. Van de Kar LD, Karteszi M, Bethea CL, Ganong WF (1985): Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus. Neuroendocrinology 41: 380-384
24. van Praag HM, Lemus C, Kahn R (1987): Hormonal probes of central serotonergic activity: Do they really exist? Biol Psychiatry 22:86-98